Internal Medicine · Ammon, ID
NPI
1336273085
Since 2007
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
2705 E 17th St
Ammon, ID, 83406
Phone (208) 346-7500
Groups this clinician bills Medicare through
Medicare paid, 2024
$72K
1,000 services
Medicare patients, 2024
87
Average age 57
Drug cost, 2024
$2.1M
7,418 prescriptions
Company payments, 2025
$618
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Stephen A Denagy was code 90834 (psychotherapy - nongroup), 344 times for 24 patients. In total Stephen A Denagy billed 1,000 services in 25 codes, and Medicare paid $72K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-04-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 90834 Psychotherapy - Nongroup | Office | 344 | 24 | $72.72 | $25K |
| 90833 Psychotherapy - Nongroup | Office | 87 | 56 | $47.67 | $4,148 |
| 99215 Office E&M - Established | Office | 87 | 52 | $122.14 | $11K |
| 99214 Office E&M - Established | Office | 78 | 49 | $79.84 | $6,228 |
| 90838 Psychotherapy - Nongroup | Office | 37 | 29 | $86.90 | $3,215 |
| 90836 Psychotherapy - Nongroup | Office | 35 | 26 | $67.52 | $2,363 |
| 90791 Psychotherapy - Nongroup | Office | 15 | 14 | $127.12 | $1,907 |
By year: 2022 $118K for 1,788 services; 2023 $73K for 1,093 services; 2024 $72K for 1,000 services.
Medicare prescription drug claims, 2024
In 2024, the drug Stephen A Denagy prescribed most often to Medicare patients was Lamotrigine, with 236 prescriptions and refills. In total Stephen A Denagy wrote 7,418 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Lamotrigine Generic | 236 | 285 | 31 | $1,875 |
| Lithium Carbonate Generic | 231 | 259 | 28 | $2,020 |
| Prazosin Hcl Generic | 211 | 259 | 22 | $4,567 |
| Quetiapine Fumarate Generic | 210 | 252 | 26 | $4,201 |
| Clozapine Generic | 204 | 204 | 18 | $26K |
| Trazodone Hcl Generic | 204 | 261 | 29 | $1,776 |
| Duloxetine Hcl Generic | 194 | 272 | 26 | $4,041 |
| Gabapentin Generic | 185 | 227 | 28 | $2,876 |
| Lurasidone Hcl Generic | 182 | 187 | 21 | $42K |
| Divalproex Sodium Generic | 179 | 192 | 21 | $10K |
| Trintellix Vortioxetine Hydrobromide | 175 | 189 | 20 | $88K |
| Lorazepam Generic | 170 | 170 | 22 | $1,227 |
| Clonazepam Generic | 167 | 175 | 20 | $1,457 |
| Olanzapine Generic | 164 | 174 | 20 | $10K |
| Metformin Hcl Generic | 152 | 184 | 22 | $939 |
Brand drugs: - claims; generic drugs: 6,189 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Stephen A Denagy $618 ($618 in general payments such as food, travel and fees) from 13 companies. The largest payer was ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) with $153.
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 6 | $153 |
| Indivior Inc. INDV | 3 | $79.7 |
| Neurocrine BioSciences, Inc. NBIX | 4 | $72.21 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 4 | $67.62 |
| Abbvie Inc. ABBV | 3 | $63.01 |
| Corium, LLC | 4 | $35.41 |
| Teva Pharmaceuticals USA, Inc. TEVA | 2 | $34.98 |
| Vanda Pharmaceuticals Inc. VNDA | 1 | $30.3 |
| Janssen Pharmaceuticals, Inc JNJ | 1 | $18.55 |
| Lundbeck LLC | 1 | $16.59 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.